Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Meet The New CEO of Bristol Myers-Squibb

May 5, 2015 3:34 pm | by Linda A. Johnson, AP Business Writer | News | Comments

Caforio is a physician - a rarity in the biopharmaceutical industry, where most executives trained in law, marketing and business management. Read more...


Diabetes Glucose and Alzheimer’s Brain Plaques Could be Connected

May 5, 2015 12:05 pm | by Seth Augenstein, Digital Reporter | News | Comments

Diabetes and Alzheimer’s could have a cause-and-effect connection, according to a study published this week. Elevated glucose in the blood caused increased levels of amyloid beta, a fundamental ingredient of brain plaques in Alzheimer’s brains, in mice analyzed by the team from the Washington University School of Medicine in St. Louis. Read more...


Kowa Pharmaceuticals: Pitavastatin Safe Compared with Placebo, Other Statins

May 5, 2015 11:39 am | News | Comments

Kowa Pharmaceuticals America, Inc., announced that the results of a meta-analysis of 15 randomized, controlled clinical trials, to assess the effects of Livalo (pitavastatin) on glycemic parameters and new-onset diabetes (NOD) in non-diabetic individuals were presented as a late-breaking abstract at the 83rd European Atherosclerosis Society (EAS) Congress held in Glasgow, UK. Read more..


Bayer Licenses ISIS FXIRx from Isis Pharmaceuticals

May 5, 2015 11:33 am | News | Comments

Bayer HealthCare (Bayer) has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Read more...


Discovery Could Reverse Glucocorticoid Resistance in Young Leukemia Patients

May 5, 2015 11:26 am | by St. Jude Children's Hospital | News | Comments

St. Jude Children's Research Hospital study lays the foundation for more effective treatment of childhood leukemia and a wide range of other disorders using small molecules to reverse glucocorticoid resistance. Read more...


Hepatitis C Therapy Clears Virus in 93% of Patients in BMS-Funded Trial

May 5, 2015 11:11 am | by Stephanie Guzowski, Editor | Articles | Comments

Bristol-Myers Squibb is trying its hand at its own combination of drugs — daclatasvir, asunaprevir, and beclabuvir. A 12-week dose of the investigational three-drug hepatitis C combination cleared the virus in 93 percent with liver cirrhosis who hadn’t previously been treated, finds a study, published today in The Journal of the American Medical Association (JAMA). Read more...


China to Lift Price Controls on Most Drugs Starting June 1st

May 5, 2015 8:35 am | by The Associated Press | News | Comments

Chinese regulators will lift price controls on most pharmaceutical drugs starting June 1 in hopes that the market-driven pricing system will keep medical costs in check. Read more...


Prostate Cancer Treatment Market Value Will Triple to $8.2B by 2023

May 5, 2015 8:33 am | by Raksha Mudbhary, Ph.D., GlobalData Senior Oncology Analyst | Articles | Comments

The global treatment market value for prostate cancer, excluding hormonal and bone therapies, will expand more than threefold from $2.6 billion in 2013 to an estimated $8.2 billion by 2023. Read more...


Researchers "Un-Can" the HIV Virus

May 5, 2015 8:32 am | by University of Montreal | News | Comments

Researchers have identified a way to use a can opener to force the HIV virus to open up and to expose its vulnerable parts. Read more...


Study Points to Possible Treatment for Lethal Pediatric Cancer

May 5, 2015 8:32 am | by National Institute of Health | News | Comments

NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death. Read more...


UniQuest, AstraZeneca Collaborate on Drug Discovery

May 5, 2015 8:31 am | by University of Queensland | News | Comments

AstraZeneca and UniQuest have formed an open innovation program to support academic research that holds promise of new therapeutic drugs. Read more...


Former President Clinton Praises Liberia Progress on Ebola

May 5, 2015 8:31 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

Former President Bill Clinton said Monday he was pleased to see Liberia's progress in the fight against the deadly Ebola disease, and urged residents of the West African nation to support those who survived. Read more...


Gilead's Hepatitis C Drugs Made About $4.45B in Sales in Q1

May 4, 2015 3:06 pm | by Ryan Bushey, Associate Editor | Articles | Comments

This news greatly surpassed analyst expectations.


Multiple Types of Resistance to New Lung Cancer Drug Identified

May 4, 2015 12:09 pm | by Dana-Farber Cancer Institute | News | Comments

After identifying three different types of resistance to a promising investigational lung cancer drug in a phase 1 trial, a team of researchers led by Dana-Farber Cancer Institute scientists say new targeted inhibitors and combinations are urgently needed to stay ahead of tumors' constant and varied molecular shape-shifting. Read more...


Texas Takes Aim at Telemedicine Care for Patients

May 4, 2015 11:57 am | by David Warren, Associated Press | News | Comments

The state of Texas and telemedicine advocates are in a legal tussle over patients who receive doctor consultations through video. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.